Antipseudomonal activity of carbapenem antibiotics

Japanese Journal of Antibiotics

Volumn 53, Issue 7, 2000, Pages 479-511

  Sunagawa, M ^a   Kanazawa, K ^a   Nouda, H ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; BIAPENEM; CARBAPENEM DERIVATIVE; CEFTAZIDIME; IMIPENEM; MEROPENEM; PANIPENEM; PENICILLIN G; THIENAMYCIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; CONTROLLED STUDY; DRUG SELECTIVITY; GRAM NEGATIVE INFECTION; IC 50; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STRUCTURE ACTIVITY RELATION;

BETA-LACTAMASES; CARBAPENEMS; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MICROBIAL; PSEUDOMONAS AERUGINOSA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033849241     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Thienamycin, a new β-actam antibiotic. I. Discovery and isolation
2. N-Acetimidoyl- and N-formimidoylthienamycin derivatives: Antipseudomonal β-lactam antibiotics
3. Thienamycin, development of imipenem-cilastatin
4. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems
5. Epithienamycins-Novel β-lactams related to thienamycin I. Production and antibacterial activity
6. Structure-activity relationship of 1β-methyl-carbapenem to its antibacterial activity: Effect to the C-2 side chain and the 1β-methyl group
7. Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa
8. In vitro and in vivo antibacterial activities of S-4661, a new carbapenem
9. Mechanism of enhanced antipseudomonl activity of BO-2727, a new injectable 1-β-methyl carbapenem
10. Effects of β-lactamse inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa
11. Meropenem resisitance in Pseudomonas aeruginosa
12. Competition of β-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: Comparison with antibacterial activity and effects upon bacterial mophology
13. Biochemical comparison of imipenem, meropenem and biapenem: Permeability, binding to penicillin-binding proteins, and stability to hydrolysis by β-lactamses
14. Antibacterial activity of meropenem against Gram-negative bacteria with a permeability defect and against staphylococci
15. The effect of 1β-methyl and imidoyl substituents on the antipseudomonal activity of carbapenems
16. Outer membrane permeability in Pseudomonas aeruginosa: Comparison of a wild-type with an antibiotic-supersusceptible mutant
17. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes
18. Penetration of β-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: Comparison of a highly sensitive mutant with its parent strain
19. Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: A quantitative predictive treatment
20. Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane
21. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa
22. Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides
23. A functional classification scheme for β-lactamases and its correlation with molecular structure
24. Livermore: In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms
25. Interplay between chromosomal β-lactamase and MexAB-OprM eflux system in intrinsic resistance to β-lactams in Pseudomonas aeruginosa
26. Resistance to β-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and β-lactamse
27. Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than the OprD porin channel
28. Penetration of meropenem in Gram-negative bacilli. Difference in activity with imipenem
29. Interplay of impermeability and chromosomal b-lactamase activity in imipenem-resistant Pseudomonas aeruginosa
30. Carbapenem activities against Pseudomonas aeruginosa: Respective contributions of OprD and efflux systems
31. The effect of 1β-methyl substituent and the basicity in C-2 side chain in carbapenem antibiotics on the activity against Pseudomonas aeruginosa oprD2 and nalB mutants
32. Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate
33. β-Lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime
34. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of Gram-negative bacilli
35. Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects
36. Carbapenem-induced endotoxin release in Gram-negative bacterial sepsis rat models
37. Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin
38. Early effects of β-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa
39. Imipenem antagonism of the in vitro activity of the piperacillin against Pseudomonas aeruginosa
40. Imipenem-induced resistance to antipseudomonal β-lactams in Pseudomonas aeruginosa
41. Beta-Lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity
42. Structure-activity relationships of carbapenems to the antagonism of the antipseudomonal activity of other β-lactam agents and to the β-lactamse inducibility in Pseudomonas aeruginosa: Effects of 1β-methyl group and C-2 side chain
43. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in Gram-negative bacteria
44. The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide
45. Role of penicillin-binding proteins in the initiation of the AmpC β-lactamase expression in Enterobacter cloacae